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Classification of Foreign Body Reactions due to Industrial
Silicone Injection
Ago Harlim, MD, MHA, PhD,* Mpu Kanoko, MD, PhD,† and Siti Aisah, MD, PhD‡
BACKGROUND A foreign body reaction (FBR) is a typical tissue response to a biomaterial that has
been injected or implanted in human body tissue. There has been a lack of data on the classification of
foreign body reaction to silicone injection, which can describe the pattern of body tissue responses to
silicone.
OBJECTIVE Determine the foreign body reaction to silicone injection.
METHOD Wemodified the classification proposed by Duranti and colleagues, which has categorized a FBR to
hyaluronic acid injection into a new classification of an FBR to silicone injection. A cohort study of 31 women
suffering from silicone-induced granulomas on their chin was conducted. Granulomatous tissue and sub-
mental skin were stained with hematoxylin–eosin and evaluated.
RESULTS Our data revealed that there were at least 7 categories of FBRs to silicone injection that could be
developed. Categories 1 to 4 showed inflammatory activity, and categories 5 to 8 showed tissue repair by
fibrosis.
CONCLUSION Using histopathological staining, we are able to sequence the steps of body reactions to sil-
icone injection. Initial inflammatory reaction is then replaced by fibrosis process repairing the damaged tis-
sues. The process depends on the host immune tolerance.
The authors have indicated no significant interest with commercial supporters.
Filling materials are used for reconstruction of bodyparts with congenital or traumatic damage.
Discoveryof stablematerials deemed tobe“inert”by the
human body has allowed more extensive use of these
ﬁlling materials. Nevertheless, almost all medical-grade
ﬁlling materials can trigger a “foreign body reaction”
(FBR) in the human body tissue. Foreign body reactions
can be caused by the chemical properties of thematerials
or inappropriate application.1
Silicone is the most inert and permanent ﬁlling
material compared with hyaluronic acid, poly-
methylmethacrylate, and collagen.2 In addition, its
stability and nontoxic properties make it an ideal ﬁlling
material. The hydrophobicity of silicone, however, trig-
gers adsorption of plasma proteins on the surface of sili-
cone, and a “protein matrix” is formed. The latter
triggers the immune system: blood clotting, ﬁbrinolysis,
and activation of kinin and complement systems. In
addition, various cytokines, chemokines, and growth
factors in the matrix on the silicone surface cause acti-
vationof certain immune cells. This sequenceof reactions
is called the“Vroman effect.”3An inﬂammatory reaction
at the silicone surface produces a microenvironment
containing tumor necrosis factor (TNF) a, which in turn
triggers maturation of extracellular matrix (ECM)
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proteins within ﬁbroblasts, thereby causing ﬁbrosis.4
When liquid silicone is injected into tissue, the silicone
forms “microdroplets” of 20 to 100 mm2 that can
migrate to other areas because of gravity. There are 2
types ofmigration, that is, a large-volume silicone, which
migrates along tissueplanes, and a small-volume silicone,
which will stay in the tissue and will have undergone
phagocytosis by macrophages into small microdroplets.
Microdroplets of <15 mmmay undergo further phago-
cytosis by macrophages and will be transported through
lymphatic vessels. By contrast, large microdroplets can-
not be phagocytosed and cause macrophages to become
activated on the silicone surface. In addition, the reaction
between silicone and the tissue creates ﬁbrous capsules
and triggers granuloma formation.2,5,6
An FBR comprises a series of inﬂammatory reactions
followed by ﬁbrosis. The nature of these reactions is
highly dependent on the immune system of the host.
Thus, to observe this series of reactions and identify the
category of the FBR, biopsies of granulomatous tissue
should be performed because biopsy is a more reliable
evaluation than measuring cytokine levels in blood.
Duranti and colleagues7 divided FBRs into 4 catego-
ries. Our research team, however, do not consider
their categories to be suitable for assessment of FBRs
to injected silicone. We believe that the dynamics of
inﬂammatory cells in body tissue and surface of
ﬁbrotic areas can be used to identify a speciﬁc category
of FBRs at a particular time. When inﬂammatory
reaction caused by injected silicone has started to
diminish, ﬁbrosis appears; therefore, it can serve as
a marker that tissue repairing is underway. Hence, we
assumed that the area of ﬁbrosis could also be
amarker for determining FBR categories. In this study,
we proposed a category of FBRs based on the severity
of inﬂammatory reactions, degree of tissue repair, and
sequence of immune responses.
Materials and Methods
Patients
The participants in our study were 31 Indonesian
women aged 20 to 55 years who had received
industrial silicone injection on their chin and sub-
sequently had suffered granulomatous reactions.
Thirty-seven specimens of normal skin from patients
who had been scheduled to undergo facelift surgery
served as the control group. The silicone content was
analyzed using atomic absorbance spectroscopy
(AAS). The analysis was conducted to conﬁrm
whether the granulomatous reactions were caused by
silicone or by other ﬁlling materials. Written
informed consent was obtained from all participants
before specimen collection.
Specimen Collection and Foreign Body
Reaction Classification
Specimenswere collected from thepatientswhohadbeen
scheduled to undergo granuloma removal. Specimens
were collected from the granuloma site, skin surrounding
the granuloma, and normal skin in the same patient.
Specimens of normal skin were collected from patients
who had been scheduled to have a facelift surgery. From
each chin, specimens of granulomatous tissue due to sil-
icone injection and submental skin tissues surrounding
the granuloma were obtained. Thirty-one specimens
from the granuloma site and 31 specimens from sub-
mental skin in the samepatientswere obtained.A total of
62 specimens were collected. For control samples, 37
specimens of normal skin were collected from the skin
belowtheearafter facelift surgeries. Specimenswereﬁxed
in buffered formalin and embedded in parafﬁn.
The specimens were then stained using hematoxylin–
eosin, which were conducted at the Department of
Pathology of our institution. Observations were made
on 5 ﬁelds of view on each slide at 400·magniﬁcation.
Histologic assessments included extravasation of
inﬂammatory cells around silicone droplets, the
number of giant cells, and areas of ﬁbrosis. We used
a double-blind method with 2 examiners for each
specimen to ensure that there was an agreement
regarding the category of FBRs to silicone injection. If
the 2 examiners disagreed, a third examiner was
consulted to make a ﬁnal decision.
For this study,weproposed8categoriesofFBRsbasedon
the severity of inﬂammatory reaction and the extent of
tissue repair because of immune responses. The following
categories were used for statistical analyses (Figure 1):
Category 1, no visible reaction; Category 2,mild reaction
with few inﬂammatory cells; Category 3, inﬂammatory
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cells with one or 2 giant cells; Category 4, inﬂammatory
cells with more than 2 giant cells and <50% of the area
undergoing ﬁbrosis; Category 5, inﬂammatory cells with
more than 2 giant cells and >50%of the area undergoing
ﬁbrosis;Category6, inﬂammatorycellswithonegiant cell
and >50% of the area undergoing ﬁbrosis; Category 7,
<50% of the areas are ﬁbrotic with no giant cells; and
Category 8, >50% of the areas are ﬁbrotic with no giant
cells. Categories 2 to 4were determinedwhen FBRswere
dominated by inﬂammatory activity. Categories 5 to 8
were determined when FBRs had been led to ﬁbrosis and
tissue repair.
Results
Atomic absorbance spectroscopy results showed that
silicone levels were 4.1 to 10,430 mg/g in granuloma-
tous tissues and 0 to 6,065 mg/g in submental skin
tissue for all FBR categories. These ﬁndings are sur-
prising because the mean level of silicone in normal
skin is 44.07 mg/g. Specimens were obtained from
patients who had received silicone injections 3 to 25
years previously. Mean age of onset for granuloma
symptoms was 12.5 years (Table 1).
An inﬂammatory process was found as the initial FBR
response (Figure 2). Category 4 of FBR reﬂected the
peak inﬂammatory activity in tissues, which was char-
acterized by the large number of giant cells. Fibrotic
tissue was not yet widespread. Category 4 (i.e.,
inﬂammatoryactivity) seemed topeakat10 to19years.
Hence, the mean age of onset of granuloma-associated
symptoms was 12.5 years (i.e., the time at which the
patient came to us because of granuloma-associated
symptoms). It seemed that inﬂammation tended to
decrease after 19 years of age.
Histopathological examination showed that samples
from the normal group were in Categories 1 and 2 only.
Most samples in the granuloma group were included in
FBRCategories 3 and 4, whereas those in the submental
skin group had Categories 2 and 3 (Table 2). Therefore,
peak inﬂammatory reactionwas found in the granuloma
group, and in the submental group (i.e., those with
sample skin near the granuloma), the inﬂammatory
reactions increased and reached the level of inﬂamma-
tion as high as those observed in the granuloma group.
Figure 1. Categories of foreign body reactions to injected
silicone. Category 1: No visible reaction. Category 2: Mild
reaction with a few inflammatory cells. Category 3: Inflam-
matory cells and one or 2 giant cells. Category 4: Inflam-
matory cells and more than 2 giant cells. Less than 50% of
the area is fibrotic. Category 5: Inflammatory cells and more
than 2 giant cells. Less than 50% of the area is fibrotic.
Category 6: Inflammatory cells and one giant cell. Less than
50% of the area is fibrotic. Category 7: Less than 50% of the
area is fibrotic. No giant cells. Category 8: Less than 50% of
the area is fibrotic. No giant cells.
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Moreover, there was a correlation between the gran-
uloma group and submental skin group (r = 0.507,
p = .004) (Table 3). Also, there was a correlation
between the onset of granuloma-associated symptoms
andhistopathologicalﬁndings in the granulomagroup
(p = .020) (Figure 2) as well as in the submental skin
group (p = .046) (Figure 3).
Discussion
Silicone levels were 4.1 to 10,430 mg/g in granulo-
matous tissues and 0 to 6,065 mg/g in submental skin
tissue for all FBR categories, whereas themean level of
silicone in normal skin is 44.07 mg/g (Table 1). It has
been known that silicone has been widely used in
everyday life, such as for households, microchips,
computers, electronics, and cosmetics, including for
various medications starting from antacids, syringes
to mineral waters. Although we have not known how
much silicone has been absorbed by our body, silicone
is an essential mineral for our bone strength and
elasticity. The human body needs silica about 24 to 33
mg/d. Some foods are high in silica content, such as
grist, sugar cane, strawberry, and cereal.8,9
Our histopathologicalﬁndings showed that samples in
the normal group shared characteristics in Categories
1 and 2 only. The characteristics of the sample in
Category 1 were those with no visible reaction,
whereas in Category 2, there were mild reactions with
few inﬂammatory cells. It can occur because female
patients might have used skin care or other facial
treatment before they decided to have the face lift.
Although those samples had inﬂammatory cells, the
process ofmacrophage changes into datia cellswas not
initiated. Datia cells are important characteristic signs
of FBR.
At ﬁrst, we used Duranti’s FBR classiﬁcation for his-
topathological on granulomatous tissues; however,
we subsequently found 7 of 8 categories (Table 2). It
seemed that the granulomatous histopathological
features caused by the silicone injections were started
from Category 2, which was then followed by greater
inﬂammation and reached the greatest in Category 4.
In Category 5, there was also great inﬂammation;
however, dominant ﬁbrosis process had taken place
and the inﬂammation subsided, and ultimately, there
was >50% ﬁbrosis without any inﬂammation in Cat-
egory 8 (Figure 1). It is also consistent with Figure 2,
which shows the highest onset of the patients’ visit due
to the complaints of granuloma at Category 4, that is,
between 10 and 19 years. It was consistent with the
history taking, that is, the patients came with granu-
loma complaints with mean age of onset of 12.5 years
(Table 1). In Table 2, it can be seen that the skin
adjacent to the granuloma, that is, the submental skin,
seemed to be more likely to have inﬂammatory
changes similar to the granulomatous areas. Most
cases of submental skin were found in Categories 2
and 3,whereasmost cases of granulomawere found in
Categories 3 and 4, and there was a correlation
TABLE 1. Clinical Examination, Onset of Granuloma Symptoms, and Silicone Concentration for Subjects
of Different Age Categories
Variables
Normal Control
Group (n = 37)
Chin Granuloma
Group (n = 31)
Submental Skin
Group (n = 31)
Age (yr), X 6 SD 47 (28–55) 40.1 6 8.78 40.1 6 8.78
Clinical examination, %
Mild 6 (19.4%)
Moderate 18 (58.1%)
Severe 7 (22.6%)
Onset of granuloma symptom (yr) 12.5 6 5.5 12.5 6 5.5
Silicone concentration (mg/g), median
(minimum–maximum)
0 (0–253) 688 (4.1–10,430) 944 (0–6,065)
X, mean; clinical examination, graded granuloma by clinical examination. Mild, nodule <3 cm; moderate, nodule 3 to 6 cm, or nodule <6
cm with redness <3 cm; severe, nodule expanding out of the chin or redness >3 cm. Onset of granuloma symptoms: time from injection
of the silicone to time when patient complains about the symptom or comes to visit the doctor.
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between the granulomaFBR in the chin and submental
skin (Table 3, p = .004).
Specimenswereobtained frompatientswhohad received
silicone injections 3 to 25 years previously. Mean age of
onset of granuloma symptoms was 12.5 years (Table 1).
We presume that the onset of granuloma symptoms
depends on the host’s immune system. Interaction
between silicone antigen with or without infection and
immune tolerance status can induce delayed hypersensi-
tivity, which may cause granuloma symptoms.
Silicone is composed of nonbiodegradablemolecules;
therefore, it can persist in tissue long after it has been
injected. Its persistence is due to its large molecular
size and physical–chemical stability. Large-volume
silicone after the injection will migrate along tissue
planes, and small volume will stay in the tissue and
will be phagocytosed by macrophages into small
microdroplets (Figure 4). Microspheres of <15 mm in
size are generally phagocytosed and transported to
local lymph nodes. However, some larger micro-
spheres from nonresorbable polymers with a smooth
surface are encapsulated by ﬁbrous tissue and escape
phagocytosis.2
Giant cell formation is the result of fusion of several
local macrophages. Such formation suggests that there
is a chronic inﬂammation caused by persistence of
a foreign material (e.g., silicone) in tissue.10 Macro-
phages phagocytose silicone, and thereby, reducing
the size of the silicone deposits (Figure 4). Macro-
phages release cytokines, such as TNFa. Tumor
necrosis factor a activity may have been dominant in
Categories 2 to 4 and may have been a key factor in
initiation of ﬁbrosis (categories 5–8).
Macrophages are major producers of matrix metal-
loproteinases and tissue inhibitors of matrix metal-
loproteinases. The balance in the level of these
Figure 2. Association of 8 foreign body reaction categories and the onset of granuloma in the granuloma group. The onset
of granuloma symptom can be divided into 3 Categories 1, 0 to 9 years; 2, 10 to 19 years; 3, >19 years. cCurve estimation
quadratic and cubic test; *p # .05; R2: Coefficient of determination for histopathology examination and the 8 foreign body
reaction categories. Foreign body reactions due to injected silicone show inflammatory response followed by fibrosis. The
inflammatory response peaks at 10 to 19 years, followed by decreasing activity until 25 years. Decreasing inflammatory
activity was followed by increasing fibrotic activity to initiate tissue repair.
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proteins determines whether collagen from the ECM
of local ﬁbroblasts is formed or degraded. Initially,
interleukin (IL)-6 is also involved in acute inﬂam-
mation. Then, IL-6 changes its characteristics and
helps T-helper (Th) lymphocytes, making Th1 lym-
phocytes the predominant cell type (in the inﬂam-
matory categories). Afterward, they are polarized
into Th2 lymphocytes (during anti-inﬂammatory
categories). In this category, IL-13 (a product of Th2
lymphocytes) activity increases and triggers ﬁbro-
blast proliferation, which causes ﬁbrosis.4 The phe-
nomenon is shown in Figure 1, that is, the
inﬂammatory response increased from Category 2 to
Category 4, and the ﬁbrotic process was developed
during Categories 5 to 8. It seems that there is a shift
of Type-1 lymphocytes in Categories 2 to 4 to Type-2
lymphocytes in Categories 5 to 8.
In the FBR classiﬁcation described by Duranti and
colleagues,7 the peak of Stage 4 is reached when the
implant is encapsulated with an obvious FBR. None-
theless, the value of Stage 4 FBR in their study when
applied to injected silicone was not conﬁrmed. It
seemed that there is a difference; therefore, we modi-
ﬁed the sequential categories for FBRs.
Eight categories were proposed to describe FBRs
regarding injected silicone, which assessed inﬂam-
matory and tissue repair responses over a period.
Categories 2 to 4 describe the dynamics of the
inﬂammatory process with a peak activity marked by
numerous giant cells and ﬁbrosis of <50% in tissue,
whereas in Category 5, there are still great inﬂam-
mation with numerous datia cells, but the ﬁbrosis are
also abundant, which is >50%. Categories 6 to 8
covers the sequential reactions of ﬁbrotic response,
which is marked by the decrease (or absence) of
inﬂammatory cells in the tissue and increased ﬁbrosis
up to $50%.
The pathologic FBR to a foreign body is dependent on
the characteristics of the immune system, which is
under genetic control.11 Therefore, tissue responses to
silicone injections vary among patients even during the
same period of injection. Th1 lymphocytes have roles
during inﬂammation (Categories 2–4), whereas Th2
lymphocytes have roles in tissue repair during ﬁbrosis
(Categories 5–8). Fibrosis is supported by cytokines,
which was produced by Th2 lymphocytes, and it is
also supported by regulatory T (Treg) lymphocytes,
which release transforming growth factor (TGF)b and
IL-10. TGFb1 is known to support ﬁbrosis.
Activity of Treg lymphocytes increases to control the
inﬂammation occurring in the tissue. Persistence of
Treg lymphocytes in tissue can be affected by ECM
proteins, such as hyaluronan. The presence of hya-
luronan is a sign that the tissue is no longer damaged,
signaling that Treg lymphocytes should stop contrib-
uting to an anti-inﬂammatory response.12 Cellular
TABLE 2. Categories of Histopathology
Examination in the Normal, Granuloma, and
Submental Skin Group
Category
Normal
(n = 37)
Granuloma
(n = 31)
Submental
Skin (n = 31)
N N N
Category 1 13 0 0
Category 2 24 4 12
Category 3 0 10 9
Category 4 0 9 3
Category 5 0 4 2
Category 6 0 0 1
Category 7 0 2 1
Category 8 0 2 3
TABLE 3. Comparison of Histopathology
Between the Granuloma and Submental Skin
Group
Histopathology
Granuloma
Submental
Skin
pN N
Category 1 0 0 p1 = .004*†
Category 2 4 12 r1 = 0.507
Category 3 10 9 R2 = 0.258
Category 4 9 3
Category 5 4 2
Category 6 0 1
Category 7 2 1
Category 8 2 3
*Spearman test.
†p # .05.
R2, coefficient of determination.
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activity of Treg lymphocytes (e.g., TGFb1 secretion) is
in an autocrine manner for differentiation of Treg
lymphocytes in peripheral circulation.13 However,
TGFb1 is a potent cytokine that supports ﬁbrosis.
Hence, Treg lymphocytes may also have a role in the
ﬁbrosis caused by injected silicone.
The ﬁbrotic process is often interpreted in the context
of tissue repair, and this ﬁbrotic activity is persistent.
Excessive ﬁbrosis causes dysfunctional tissue at phys-
iological level; however, ﬁbrosis remains an important
stage in repair of damaged tissue. Collagen proteo-
glycans and some ECM proteins are essential
components for ﬁlling damaged tissue. Their pro-
duction is stopped automaticallywhen damaged tissue
has been replenished by ECM proteins.14,15 An FBR is
dependent on T-helper lymphocytes. Th1 lympho-
cytes predominate in the inﬂammation stage, and Th2
lymphocytes predominate in the ﬁbrotic stage. Other
cells, such as Treg lymphocytes, are involved in
immune tolerance; however, their roles in FBRs
necessitate further investigation.
All granulomas can be considered as dynamic struc-
tures, which are composed of multiple cell types. They
commonly share a general characteristic, that is, the
Figure 3. Association of 8 foreign body reaction categories and the onset of granuloma in the submental skin group. The
onset of granuloma symptom can be divided into 3 Categories: 1, 0 to 9 years; 2, 10 to 19; years; 3, >19 years. cCurve
estimation quadratic and cubic test; *p # .05, R2: Coefficient of determination for histopathology examination and the 8
foreign body reaction categories.
Figure 4. Process of phagocytosis. (A) Fusion of a macrophage with a giant cell. The giant cell is phagocytizing silicone,
reducing its overall size. (B) An area with more giant cells and a reduced amount of silicone.
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presence of a central accumulation of mononuclear
cells, which is surrounded by activated T cells and
cytokine release. The inﬂammatory granulomatous
response depends on antigen involved in the granu-
loma formation, which is also associated with the
predominant Th1 and Th2 as well as the pattern of
cytokine production. It explains the speciﬁc patho-
logical features found in granulomas.16
Similar to granuloma associated with sarcoidosis or
mycobacteria infection, the dominant cytokine is IL2,
which tends to indicate Type-1 granuloma,16 whereas
in the FBR caused by silicone, there is ﬁbrosis, which
suggests a Type-2 granuloma.
We observed that there were at least 2 types of FBR
during tissue repair. First, there was an inﬂammatory
response followed by mild ﬁbrosis of Categories 2 to
4 and 7. These responses resulted from attempts to
repair damaged tissue after inﬂammatory process.
Second, the inﬂammatory response was followed by
development of severe ﬁbrosis of Categories 2 to 6
and 8. Thus, it indicates that the physiological func-
tion of tissue was diminished after the ﬁbrotic process
was complete. It can be assumed that when the
immune response of an individual is good, the
inﬂammatory process can be suppressed, and there
will be less ﬁbrosis resulting in less tissue damage as
found in patients with FBR Categories 2 to 4 and 7.
Further studies on immune system and the interaction
between silicone antigen and immune tolerance that
contribute to delayed hypersensitivity and tissue
repair should be investigated in the future.
In terms of clinical application, our study has revealed
FBRcategories for the ongoingprocess. If a granuloma
is still in the inﬂammation stage, we suggest that it
should be removed as soon as possible to avoid an
extended period of inﬂammation, which would
enlarge the granulomatous nodule. Tissue repair will
continue, but the development ofﬁbrosis could be kept
to a minimum level and thereby improve cosmetic
appearance. If ﬁbrosis has been started, we suggest
that the granuloma is removed as early as possible for
the same reason, that is, to reach better cosmetic effect.
In this study, the patients sought treatment because of
their granulomas.
When the granuloma cannot be removed, other
modalities can be given after wound healing period,
such as using intralesion corticosteroid injection,
which is 15- to 20-mg/mL triamcinolone every 2
months as well as topical treatment of pimetacroli-
mus b.i.d. for 3 months and topical imiquimod for 8
weeks. Other treatments include minocycline, allo-
purinol, and oral prednisone of 30 mg/d. However,
when the results of those treatments are still not sat-
isfying, intralesional injection of triamsinolone is
more signiﬁcant to overcome the occurring
inﬂammation.17,18
Etanercept, which works on TNF-a receptor and
binds the Fc domain of IgG isotypes, has been reported
to have a good effect on silicone-associated granu-
loma. A subcutaneous administration of 50 mg twice
a week or 25 mg twice weekly has provided a quite
satisfying result.19–21 Further studies are necessary to
discover therapy or medications that can suppress
TNF-a cytokines in patients with granuloma because
of silicone injection or on therapy that can increase the
body tolerance.
The limitation of our study was that we evaluated the
FBR to injected silicone-only histopathological
examination. More studies need to be performed on
how the inﬂammation disappears and ﬁbrosis starts,
which may depend on the subject’s immune tolerance.
Our study only used unpuriﬁed industrial silicone,
and therefore, it may contain other substances that
may cause immune response. The impurity signiﬁes
its difference with the medical-grade liquid silicone;
however, it has the same basic ingredient of liquid
silicone, that is, dimethylpolysiloxane, which still has
similar properties. The key reason of developing the
reaction is started when the liquid silicone is being
localized in the tissue, which slowly will cause
adsorption of plasma protein on the surface of the
silicone, forming a protein matrix and inducing the
recruitment of immune cells to the matrix area
resulting in nonspeciﬁc immune response in the
matrix area (Vromann effect).3,22 Although for the
unpuriﬁed industrial silicone, the immune reactions
will develop faster than those with medical-grade
silicone.
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Conclusion
Foreign body reactions to injected silicone can be
classiﬁed into at least 2 main categories, that is, reac-
tion of inﬂammation and tissue repair/ﬁbrosis. These 2
main categories can be broken down into 8 more
deﬁnitive categories. Categories 2 to 4 reﬂect inﬂam-
matory activity, whereas Categories 5 to 8 reﬂect
ﬁbrosis, which may lead to tissue repair.
Histopathological examination showed that 8 cate-
gories of FBRs because of silicone injection could be
created. Those categories could be split further into the
following 7 stages without Category 1: Stage 1 (Cat-
egory 2), mild reaction with few inﬂammatory cells;
Stage 2 (Category 3), inﬂammatory cells with one or 2
giant cells; Stage 3 (Category 4), inﬂammatory cells
with more than 2 giant cells and <50% of the area
undergoing ﬁbrosis; Stage 4 (Category 5), inﬂamma-
tory cells withmore than 2 giant cells and >50%of the
area undergoing ﬁbrosis; Stage 5 (Category 6),
inﬂammatory cells with one giant cell and >50%of the
area undergoing ﬁbrosis; and Stage 6 (Category 7),
<50% of the area now ﬁbrotic with no giant cells;
Stage 7 (Category 8), >50% of the area now ﬁbrotic
with no giant cells.
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